Citigroup »

Redhill Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Redhill Biopharma (RDHL) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Redhill Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Redhill Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Redhill Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $165 114 1.46

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Tesla Motors (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Redhill Biopharma

Gagnon Securities
Federation des caisses Desjardins du Quebec
UBS Group
Rhumbline Advisers
We Are One Seven
Two Sigma Securities
Group One Trading
Morgan Stanley
Aspire Private Capital
Royal Bank of Canada
Bank of America Corporation
Advisor Group Holdings
Wells Fargo & Company
Jpmorgan Chase & Co
IFP Advisors

View all funds holding Redhill Biopharma